Skip to content Skip to footer

Molecular Cancer Therapeutics

ISSNs: 1535-7163

Additional searchable ISSN (electronic): 1538-8514

American Association for Cancer Research Inc.

Scopus rating (2023): CiteScore 11.2 SJR 2.27 SNIP 1.016

Journal

Titles
  • Molecular Cancer Therapeutics
  • Molecular cancer therapeutics
Additional searchable titlesMolecular cancer therapeutics, Molecular cancer therapeutics.
ISSNs1535-7163
Additional searchable ISSN (electronic)1538-8514
PublisherAmerican Association for Cancer Research Inc.
ZDB-ID2063563-1
ZDB-ID2062135-8

Keywords

ASJC Scopus subject areas

Related content

Kit-dependent and KIT-independent genomic heterogeneity of resistance in gastrointestinal stromal tumors - TORC1/2 inhibition as salvage strategy

Muhlenberg, T., Ketzer, J., Heinrich, M. C., Grunewald, S., Marino-Enriquez, A., Trautmann, M. & Hartmann, W. & 14 others, Wardelmann, E., Treckmann, J., Worm, K., Bertram, S., Herold, T., Schildhaus, H. U., Glimm, H., Stenzinger, A., Brors, B., Horak, P., Hohenberger, P., Frohling, S., Fletcher, J. A. & Bauer, S., 2019, In: Molecular cancer therapeutics. 18, 11, p. 1985-1996 12 p.

Research output: Contribution to journalResearch articleContributedpeer-review

The STAT3 inhibitor galiellalactone reduces IL6-mediated AR activity in benign and malignant prostate models.

Handle, F., Puhr, M., Schaefer, G., Lorito, N., Hoefer, J., Gruber, M. & Guggenberger, F. & 6 others, Santer, F., Marques, R., van, W. W., Claessens, F., Erb, H. & Culig, Z., Sept 2018, In: Molecular cancer therapeutics.

Research output: Contribution to journalResearch articleContributedpeer-review

Arginine Deprivation Therapy: Putative Strategy to Eradicate Glioblastoma Cells by Radiosensitization

Hinrichs, C. N., Ingargiola, M., Käubler, T., Löck, S., Temme, A., Köhn-Luque, A. & Deutsch, A. & 3 others, Vovk, O., Stasyk, O. & Kunz-Schughart, L. A., Feb 2018, In: Molecular Cancer Therapeutics. 17, 2, p. 393-406 14 p.

Research output: Contribution to journalResearch articleContributedpeer-review

Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor

Zeng, S., Seifert, A. M., Zhang, J. Q., Cavnar, M. J., Kim, T. S., Balachandran, V. P. & Santamaria-Barria, J. A. & 10 others, Cohen, N. A., Beckman, M. J., Medina, B. D., Rossi, F., Crawley, M. H., Loo, J. K., Maltbaek, J. H., Besmer, P., Antonescu, C. R. & DeMatteo, R. P., Sept 2017, In: Molecular cancer therapeutics. 16, 9, p. 1954-1966 13 p.

Research output: Contribution to journalResearch articleContributedpeer-review

Inhibition of the acetyltransferases p300 and CBP reveals a targetable function for p300 in the survival and invasion pathways of prostate cancer cell lines

Santer, F. R., Höschele, P. P. S., Su, J. O., Erb, H. H. H., Bouchal, J., Cavarretta, I. T. & Parson, W. & 3 others, Meyers, D. J., Cole, P. A. & Culig, Z., Sept 2011, In: Molecular cancer therapeutics. 10, 9, p. 1644–1655

Research output: Contribution to journalResearch articleContributedpeer-review